Global Automation in Biopharma Market Research Report 2024

Publication ID:

PB506241596

Publication Date:

June 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Automation in Biopharma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Automation in Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automation in Biopharma.
Report Scope
The Automation in Biopharma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automation in Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automation in Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE
PerkinElmer
Tecan Journal
Thermo Fisher Scientific
Bruker Corporation
Peak Analysis & Automation
Sartorius
Siemens
Rockwell
Zenith (Cognizant)
RheoSense, Inc.
Werum
Emerson
TetraScience
BioProcess International
Novasep
Segment by Type
IoT
AI
Digital Twin
AR & VR
Predictive Analytics
Cloud Computing
Segment by Application
Large Pharmaceutical Factory
Small and Medium-sized Pharmaceutical Factory
Biopharmaceutical Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automation in Biopharma companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Automation in Biopharma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 IoT
1.2.3 AI
1.2.4 Digital Twin
1.2.5 AR & VR
1.2.6 Predictive Analytics
1.2.7 Cloud Computing
1.3 Market by Application
1.3.1 Global Automation in Biopharma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large Pharmaceutical Factory
1.3.3 Small and Medium-sized Pharmaceutical Factory
1.3.4 Biopharmaceutical Laboratory
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Automation in Biopharma Market Perspective (2019-2030)
2.2 Automation in Biopharma Growth Trends by Region
2.2.1 Global Automation in Biopharma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Automation in Biopharma Historic Market Size by Region (2019-2024)
2.2.3 Automation in Biopharma Forecasted Market Size by Region (2025-2030)
2.3 Automation in Biopharma Market Dynamics
2.3.1 Automation in Biopharma Industry Trends
2.3.2 Automation in Biopharma Market Drivers
2.3.3 Automation in Biopharma Market Challenges
2.3.4 Automation in Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automation in Biopharma Players by Revenue
3.1.1 Global Top Automation in Biopharma Players by Revenue (2019-2024)
3.1.2 Global Automation in Biopharma Revenue Market Share by Players (2019-2024)
3.2 Global Automation in Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Automation in Biopharma Revenue
3.4 Global Automation in Biopharma Market Concentration Ratio
3.4.1 Global Automation in Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automation in Biopharma Revenue in 2023
3.5 Automation in Biopharma Key Players Head office and Area Served
3.6 Key Players Automation in Biopharma Product Solution and Service
3.7 Date of Enter into Automation in Biopharma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Automation in Biopharma Breakdown Data by Type
4.1 Global Automation in Biopharma Historic Market Size by Type (2019-2024)
4.2 Global Automation in Biopharma Forecasted Market Size by Type (2025-2030)
5 Automation in Biopharma Breakdown Data by Application
5.1 Global Automation in Biopharma Historic Market Size by Application (2019-2024)
5.2 Global Automation in Biopharma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Automation in Biopharma Market Size (2019-2030)
6.2 North America Automation in Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Automation in Biopharma Market Size by Country (2019-2024)
6.4 North America Automation in Biopharma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Automation in Biopharma Market Size (2019-2030)
7.2 Europe Automation in Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Automation in Biopharma Market Size by Country (2019-2024)
7.4 Europe Automation in Biopharma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Automation in Biopharma Market Size (2019-2030)
8.2 Asia-Pacific Automation in Biopharma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Automation in Biopharma Market Size by Region (2019-2024)
8.4 Asia-Pacific Automation in Biopharma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Automation in Biopharma Market Size (2019-2030)
9.2 Latin America Automation in Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Automation in Biopharma Market Size by Country (2019-2024)
9.4 Latin America Automation in Biopharma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automation in Biopharma Market Size (2019-2030)
10.2 Middle East & Africa Automation in Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Automation in Biopharma Market Size by Country (2019-2024)
10.4 Middle East & Africa Automation in Biopharma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE
11.1.1 GE Company Detail
11.1.2 GE Business Overview
11.1.3 GE Automation in Biopharma Introduction
11.1.4 GE Revenue in Automation in Biopharma Business (2019-2024)
11.1.5 GE Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Automation in Biopharma Introduction
11.2.4 PerkinElmer Revenue in Automation in Biopharma Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Tecan Journal
11.3.1 Tecan Journal Company Detail
11.3.2 Tecan Journal Business Overview
11.3.3 Tecan Journal Automation in Biopharma Introduction
11.3.4 Tecan Journal Revenue in Automation in Biopharma Business (2019-2024)
11.3.5 Tecan Journal Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Automation in Biopharma Introduction
11.4.4 Thermo Fisher Scientific Revenue in Automation in Biopharma Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bruker Corporation
11.5.1 Bruker Corporation Company Detail
11.5.2 Bruker Corporation Business Overview
11.5.3 Bruker Corporation Automation in Biopharma Introduction
11.5.4 Bruker Corporation Revenue in Automation in Biopharma Business (2019-2024)
11.5.5 Bruker Corporation Recent Development
11.6 Peak Analysis & Automation
11.6.1 Peak Analysis & Automation Company Detail
11.6.2 Peak Analysis & Automation Business Overview
11.6.3 Peak Analysis & Automation Automation in Biopharma Introduction
11.6.4 Peak Analysis & Automation Revenue in Automation in Biopharma Business (2019-2024)
11.6.5 Peak Analysis & Automation Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Detail
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Automation in Biopharma Introduction
11.7.4 Sartorius Revenue in Automation in Biopharma Business (2019-2024)
11.7.5 Sartorius Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Automation in Biopharma Introduction
11.8.4 Siemens Revenue in Automation in Biopharma Business (2019-2024)
11.8.5 Siemens Recent Development
11.9 Rockwell
11.9.1 Rockwell Company Detail
11.9.2 Rockwell Business Overview
11.9.3 Rockwell Automation in Biopharma Introduction
11.9.4 Rockwell Revenue in Automation in Biopharma Business (2019-2024)
11.9.5 Rockwell Recent Development
11.10 Zenith (Cognizant)
11.10.1 Zenith (Cognizant) Company Detail
11.10.2 Zenith (Cognizant) Business Overview
11.10.3 Zenith (Cognizant) Automation in Biopharma Introduction
11.10.4 Zenith (Cognizant) Revenue in Automation in Biopharma Business (2019-2024)
11.10.5 Zenith (Cognizant) Recent Development
11.11 RheoSense, Inc.
11.11.1 RheoSense, Inc. Company Detail
11.11.2 RheoSense, Inc. Business Overview
11.11.3 RheoSense, Inc. Automation in Biopharma Introduction
11.11.4 RheoSense, Inc. Revenue in Automation in Biopharma Business (2019-2024)
11.11.5 RheoSense, Inc. Recent Development
11.12 Werum
11.12.1 Werum Company Detail
11.12.2 Werum Business Overview
11.12.3 Werum Automation in Biopharma Introduction
11.12.4 Werum Revenue in Automation in Biopharma Business (2019-2024)
11.12.5 Werum Recent Development
11.13 Emerson
11.13.1 Emerson Company Detail
11.13.2 Emerson Business Overview
11.13.3 Emerson Automation in Biopharma Introduction
11.13.4 Emerson Revenue in Automation in Biopharma Business (2019-2024)
11.13.5 Emerson Recent Development
11.14 TetraScience
11.14.1 TetraScience Company Detail
11.14.2 TetraScience Business Overview
11.14.3 TetraScience Automation in Biopharma Introduction
11.14.4 TetraScience Revenue in Automation in Biopharma Business (2019-2024)
11.14.5 TetraScience Recent Development
11.15 BioProcess International
11.15.1 BioProcess International Company Detail
11.15.2 BioProcess International Business Overview
11.15.3 BioProcess International Automation in Biopharma Introduction
11.15.4 BioProcess International Revenue in Automation in Biopharma Business (2019-2024)
11.15.5 BioProcess International Recent Development
11.16 Novasep
11.16.1 Novasep Company Detail
11.16.2 Novasep Business Overview
11.16.3 Novasep Automation in Biopharma Introduction
11.16.4 Novasep Revenue in Automation in Biopharma Business (2019-2024)
11.16.5 Novasep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

GE
PerkinElmer
Tecan Journal
Thermo Fisher Scientific
Bruker Corporation
Peak Analysis & Automation
Sartorius
Siemens
Rockwell
Zenith (Cognizant)
RheoSense, Inc.
Werum
Emerson
TetraScience
BioProcess International
Novasep

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂